Authors:
N. Stevenson Theragenics Corporation® 5203 Bristol Industrial Way Buford GA 30518 USA

Search for other papers by N. Stevenson in
Current site
Google Scholar
PubMed
Close
,
T. Bigelow Theragenics Corporation® 103 Palladium Way Oak Ridge TN 37830 USA

Search for other papers by T. Bigelow in
Current site
Google Scholar
PubMed
Close
, and
F. Tarallo Theragenics Corporation® 103 Palladium Way Oak Ridge TN 37830 USA

Search for other papers by F. Tarallo in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract  

Calutrons, centrifuges, diffusion and distillation processes are some of the devices and techniques that have been employed to produce substantial quantities of enriched stable isotopes. Nevertheless, the availability of enriched isotopes in sufficient quantities for industrial applications remains very restricted. Industries such as those involved with medicine, semiconductors, nuclear fuel, propulsion, and national defense have identified the potential need for various enriched isotopes in large quantities. Economically producing most enriched (non-gaseous) isotopes in sufficient quantities has so far eluded commercial producers. The plasma separation process is a commercial technique now available for producing large quantities of a wide range of enriched isotopes. Until recently, this technique has mainly been explored with small-scale (proof-of-principle) devices that have been built and operated at research institutes. The new TheragenicsTM facility at Oak Ridge, TN houses the only existing commercial scale PSP system. This device, which successfully operated in the 1980's, has recently been re-commissioned and is planned to be used to produce a variety of isotopes. This report will summarize the progress and the capabilities of this device and it's potential for impacting the world's supply of stable isotopes in the future. This technique now holds promise of being able to open the door to allowing new and exciting applications of these isotopes in the future.

  • Collapse
  • Expand

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation
1968
Volumes
per Year
1
Issues
per Year
12
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)